This service delivers tailored preclinical proof-of-concept, efficacy, and pharmacokinetic/pharmacodynamic studies across oncology, inflammation, and infectious disease models. It targets early-stage biotech and pharma SMEs seeking to de-risk pipelines. The goal is to demonstrate proof-of-concept, quantify exposure–response, and inform dose/regimen. The service activities include study design, fit-for-purpose model selection (syngeneic, xenograft, disease-specific), dosing and monitoring, sample collection, bioanalysis, statistical analysis, and interpretation. The expected outcomes of the service are validated datasets that support go/no-go decisions and planning for IND-enabling work. Studies are performed in-house by TCS scientists with dedicated project management to ensure quality, timelines, and clear deliverables. The duration of the service is typically aligned to compound modality and endpoints.
Price starting from €900/mouse. Pricing per mouse, including study design, experimental work in vivo and in vitro, data analysis, and reporting, is tailored based on the specific details, mouse model selected, and scope/duration of the requested project.
Prototyping & PoC
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.